Cite
Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study.
MLA
Yoo, Jae-Sung, et al. “Higher Objective Responses by Hepatic Arterial Infusion Chemotherapy Following Atezolizumab and Bevacizumab Failure than When Used as Initial Therapy in Hepatocellular Carcinoma: A Retrospective Study.” Abdominal Radiology (New York), vol. 49, no. 9, Sept. 2024, pp. 3127–35. EBSCOhost, https://doi.org/10.1007/s00261-024-04308-6.
APA
Yoo, J.-S., Kim, J. H., Cho, H. S., Han, J. W., Jang, J. W., Choi, J. Y., Yoon, S. K., Kim, S., Oh, J. S., Chun, H. J., & Sung, P. S. (2024). Higher objective responses by hepatic arterial infusion chemotherapy following atezolizumab and bevacizumab failure than when used as initial therapy in hepatocellular carcinoma: a retrospective study. Abdominal Radiology (New York), 49(9), 3127–3135. https://doi.org/10.1007/s00261-024-04308-6
Chicago
Yoo, Jae-Sung, Ji Hoon Kim, Hee Sun Cho, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, et al. 2024. “Higher Objective Responses by Hepatic Arterial Infusion Chemotherapy Following Atezolizumab and Bevacizumab Failure than When Used as Initial Therapy in Hepatocellular Carcinoma: A Retrospective Study.” Abdominal Radiology (New York) 49 (9): 3127–35. doi:10.1007/s00261-024-04308-6.